Adenovirus-Mediated Expression of CXCL10 in the Central Nervous System Results in T-Cell Recruitment and Limited Neuropathology

References

• Angiolillo AL, Sgadari C, Taub DD, Liao F, Farber JM, Maheshwari S, Kleinman HK, Reaman GH, Tosato G (1995). Human interferon-inducible protein 10 is a po-tent inhibitor of angiogenesis in vivo. J Exp Med 182: 155–162.
   PubMed Web of Science ®Google Scholar
• Asensio VC, Lassmann S, Pagenstecher A, Steffensen SC, Henriksen SJ, Campbell IL (1999). C10 is a novel chemokine expressed in experimental inflammatory demyelinating disorders that promotes recruitment of macrophages to the central nervous system. Am J Pathol 154: 1181–1189.
   Google Scholar
• Balashov KE, Rottman JB, Weiner HL, Hancock WW (1999). CCR5+ and CXCR3+ T cells are increased in multiple sclersosis and their ligands MIP-1a and IP-10 are ex-pressed in demyelinating brain lesions. Proc Nati Acad Sci US A 96: 6873–6878.
   PubMed Web of Science ®Google Scholar
• Bell MD, Taub DD, Kunkel SJ, Strieter RM, Foley R, Gauldie J, Perry VH (1996). Recombinant human adenovirus with Rat MIP-2 gene insertion causes prolonged PMN recruitment to the murine brain. Eur j Neurosci 8: 1803–1811.
   PubMed Web of Science ®Google Scholar
• Biddison WE, Cruikshank WW, Center DM, Pelfrey CM, Taub DD, Turner RV (1998). CD8+ myelin peptide-specific T cells can chemo attract CD4+ myelin peptide-specific T cells: importance of IFN-inducible protein 10. J immunol 160: 444–448.
   Web of Science ®Google Scholar
• Bonecchi, RG, Bianchi, G, Bordignon PP, D'Ambrosio D, Lang R, Borsatti A, Sozzani S, Allavena P, Gray A, Man-tovani A, Sinigaglia F (1998). Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (This) and Th2s. J Exp Med 187: 129–134.
   PubMed Web of Science ®Google Scholar
• Boztug K, Carson MJ, Pham-Mitchell N, Asensio VC, DeMartino J, Campbell IL (2002). Leukocyte infiltration but not neurodegeneration in the CNS of transgenic mice with astrocyte production of the CXC chemokine ligand 10. J Immunol 169: 1505–1515.
   Google Scholar
• Charles PC, Chen X, Horwitz MS, Brosnan CF (1999). Dif-ferential chemokine induction by the mouse adenovirus type-1 in the central nervous system of susceptible and resistant strains of mice. J NeuroVirol 5: 55–64.
   PubMed Web of Science ®Google Scholar
• Chen BP, Kuziel WA, Lane TE (2001). Lack of CCR2 re-sults in increased mortality and impaired leukocyte ac-tivation and trafficking following infection of the central system with a neurotropic coronavirus. J Immunol 167: 4585–4592.
   PubMed Web of Science ®Google Scholar
• Cole AM, Ganz T, Liese AM, Burdick MD, Liu L, Strieter RM (2001). IFN-inducible ELR- CXC chemokines dis-play defensin-like antimicrobial activity.Jimmuno1167: 623–627.
   Google Scholar
• Dufour JH, Dziejman M, Liu MT, Leung JH, Lane, TE, Luster AD (2002). IFN-y-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking. J Immunol 168: 3195–3204.
   PubMed Web of Science ®Google Scholar
• Farber JM (1997). MIG and IP-10: CXC chemokines that target lymphocytes. J Leukoc Biol 61: 246–257.
   PubMed Web of Science ®Google Scholar
• Fife BT, Kennedy KJ, Paniagua MC, Lukacs NW, Kunkel SL, Luster AD, Karpus WJ (2001). CXCL10 (IFN-y-inducible protein-10) control of encephalitogenic CD4+ T cell ac-cumulation in the central nervous system during experi-mental autoimmune encephalomyelitis. Jimmuno1166: 7617–7624.
   Google Scholar
• Flier J, Boorsma DM, van Beek PJ, Nieboer C, Stoof TJ, Willemze R, Tensen CP (2001). Differential expression of CXCR3 targeting chemokines CXCL10, CXCL9, and CXCL11 in different types of skin inflammation. J Pathol 194: 398–405.
   PubMed Web of Science ®Google Scholar
• Gattass CR, King LB, Luster AD, Ashwell JD (1994). Con-stitutive expression of interferon gamma-inducible pro-tein 10 in lymphoid organs and inducible expression in T cells and thymocytes. J Exp Med 179: 1373–1378.
   PubMedGoogle Scholar
• Gottlieb AB, Luster AD, Posnett DN, Carter DM (1988). De-tection of a gamma interferon-induced protein IP-10 in psoriatic plaques. J Exp Med 168: 941–948.
   Google Scholar
• Hancock WW, Gao W, Csizmadia V, Faia KL, Shemmeri N, Luster AD (2001). Donor-derived IP-10 initiates devel-opment of acute allograft rejection. J Exp Med 193: 975–980.
   PubMed Web of Science ®Google Scholar
• Hancock WW, Lu B, Gao W, Csizmadia V, Faia K, King JA, Smiley ST, Ling M, Gerard NP, Gerard C (2000). Require-ment of the chemokine receptor CXCR3 for acute allo-graft rejection. J Exp Med 192: 1515–1519.
   PubMed Web of Science ®Google Scholar
• Janatpour MJ, Hudak S, Sathe M, Sedgwick JD, McEvoy LM (2001). Tumor necrosis factor-dependent segmental control of MIG expression by high endothelial venules in inflamed lymph nodes regulates monocytes recruitment. J Exp Med 193: 1375–1384.
   Google Scholar
• Lahrtz F, Piali L, Nadal D, Pfister HW, Sp anaus KS, Bagiolini M (1997). Chemotactic activity on mononuclear cells in the cerebrospinal fluid of patients with viral meningitis is mediated by interferon-gamma inducible protein-10 and monocyte chemotactic protein-1. Eur J Immunol 27: 2484–2489.
   Google Scholar
• Lane TE, Asensio VC, Yu N, Paoletti AD, Campbell IL, Buchmeier MJ. (1998). Dynamic regulation of a- and /3-chemokine expression in the central nervous system during mouse hepatitis virus-induced demyelinating disease. J Immunol 160: 970–978.
   PubMed Web of Science ®Google Scholar
• Lane TE, Liu MT, Chen BP, Asensio VC, Samawi RM, Paoletti AD, Campbell IL, Kunkel SL, Fox HS, Buchmeier MJ (2000). A central role for CD4+ T cells and RANTES in virus-induced central nervous system inflammation and demyelination. J Virol 74: 1415–1424.
   PubMed Web of Science ®Google Scholar
• Liu MT, Chen BP, Oertel P, Buchmeier MJ, Armstrong D, Hamilton TA, Lane TE (2000). Neutralization of the chemokine CXCL10 reduces inflammatory cell invasion and demyelination and improves neurologic function in a viral model of multiple sclerosis. J Immunol 165: 2327–2330.
   PubMed Web of Science ®Google Scholar
• Liu MT, Armstrong D, Hamilton TA, Lane TE (2001a). Ex-pression of Mig (monokine induced by interferon-y) is important in T lymphocyte recruitment and host defense following viral infection of the central nervous system. J Immuno1166: 1790–1795.
   Google Scholar
• Liu MT, Kierstead HS, Lane TE (2001b) Neutralization of the chemokine CXCL10 reduced inflammatory cell in-vasion and demyelination and improves neurological function in a viral model of multiple sclerosis. J Im-munol 167: 4091–4097.
   PubMedGoogle Scholar
• Luster AD, Ravetch JV (1987). Biochemical characteriza-tion of a gamma interferon-inducible cytokine (IP-10). J Exp Med 166: 1084–1097.
   PubMed Web of Science ®Google Scholar
• Pang L, Ye W, Che X, Rossler BJ, Betz AL, Yang G (2000). Reduction of inflammatory response in the mouse brain with adenoviral-mediated transforming growth factor-/31 expression. Stroke 32: 544–552.
   Google Scholar
• Patel DD, Zachariah JP, Whichard LP (2001). CXCR3 and CCR5 ligands in rheumatoid arthritis synovium. Clin Im-munol 98: 39–45.
   PubMed Web of Science ®Google Scholar
• Qin S, Rottman JB, Myers P, Kassam N, Weinblatt M, Loetscher M, Koch AE, Moser B, Mackay CR (1998). The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J Clin Invest 101: 746–754.
   PubMed Web of Science ®Google Scholar
• Romagnani P, Beltrame C, Annunziato F, Lasagni L, Luconi M, Galli G, Cosmi L, Maggi E, Salvadori M, Pupilli C, Serio M (1999). Role for interactions between IP-10/Mig and CXCR3 in proliferative glomerulonephritis. J Am Soc Nephrol 10: 2518–2526.
   Google Scholar
• Shimada A, Morimoto J, Kodama K, Suzuki R, Oikawa Y, Funae O, Kasuga A, Saruta T, Narumi S (2001). Elevated serum IP-10 levels observed in type 1 diabetes. Diabetes Care 24: 510–515.
   PubMed Web of Science ®Google Scholar
• Simpson JE, Newcombe J, Cuzner ML, Woodroofe MN (2000). Expression of the interferon-gamma-inducible chemokines IP-10 and Mig and their receptor, CXCR3, in multiple sclerosis lesions. Neuropathol Appl Neurobiol 26: 133–142.
   Google Scholar
• Sorensen TL, Tani M, Jensen J, Pierce V, Lucchinetti C, Folcik VA, Qin S, Sellebjerg F, Strieter RM, Frederik-sen JL, Ransohoff RM (1999). Expression of specific chemokines and chemokine receptors in the central ner-vous system of multiple sclerosis patients. J Clin Invest 103: 807–815.
   PubMed Web of Science ®Google Scholar
• Stalder AK, Carson MJ, Pagenstscher A, Asensio VC, Kincaid C, Benedict M, Powell HC, Masliah E, Campbell IL (1998). Late-onset chronic inflammatory encephalopathy in immune-competent and severe combined immune-deficient (SCID) mice with astrocyte-targeted expression of tumor necrosis factor. Am J Pathol 153: 767–783.
   Google Scholar
• Strieter RM, Kunkel SL, Arenberg DA, Burdick MD, Polverini PJ (1995). Interferon y-inducible protein 10 (IP-10), a member of the C-X-C chemokine family, is an inhibitor of angiogenesis. Biochem Biophys Res Com-mun 210: 51–57.
   PubMed Web of Science ®Google Scholar
• Stylianou E, Yndestad A, Sikkeland LI, Bjerkeli V, Damas JK, Haug T, Eiken HG, Aukrust P, FrOland SS (2002). Effects on interferon-alpha on gene expression of chemokines and members of the tumour necrosis factor superfamily in HIV-infected patients. Clin Exp Immunol 130: 279–285.
   Google Scholar
• Tani M, Fuentes ME, Peterson JW, Trapp BD, Durham SK, Loy JK, Bravo R, Ransohoff RM, Lira SA (1996). Neutrophil infiltration, glial reaction, and neurological disease in transgenic mice expressing the chemokine N51-KC in oligodendrocytes. J Clin Invest 98: 529–539.
   PubMed Web of Science ®Google Scholar
• Vanguri P, Farber JM (1990). Identification of CRG-2. An interferon-inducible mRNA predicted to encode a murine monokine. J Biol Chem 265: 15049–15057.
   Google Scholar
• Wang X, Li X, Schmidt DB, Foley JJ, Barone FC, Ames RS, Sarau HM (2000). Identification and molecular characterization of rat CXCR3: receptor expression and interferon-inducible protein-10 binding are increased in focal stroke. Mo/ Pharmaco/ 57: 1190–1198.
   PubMed Web of Science ®Google Scholar
• Xia MQ, Bacskai BJ, Knowles RB, Qin SX, Hyman BT (2000). Expression of the chemokine receptor CXCR3 on neurons and the elevated expression of its ligand IP-10 in reactive astrocytes: in vitro ERK1/2 activation and role in Alzheimer's disease. J Neuroimmunol 108: 227–235.
   PubMed Web of Science ®Google Scholar